Angelalign Technology Inc. (HKG:6699)
Hong Kong · Delayed Price · Currency is HKD 70.30
+0.15 (0.21%)
Jan 21, 2026, 3:14 PM HKT
Angelalign Technology Market Cap
Angelalign Technology has a market cap or net worth of 11.98 billion as of January 20, 2026. Its market cap has increased by 19.42% in one year.
Market Cap
11.98B
Enterprise Value
8.92B
Revenue
2.42B
Ranking
n/a
PE Ratio
63.84
Stock Price
70.30
Market Cap Chart
Since June 16, 2021, Angelalign Technology's market cap has decreased from 66.49B to 11.98B, a decrease of -81.98%. That is a compound annual growth rate of -31.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 11.98B | 17.70% |
| Dec 31, 2025 | 10.18B | 1.63% |
| Dec 31, 2024 | 10.01B | 4.73% |
| Dec 29, 2023 | 9.56B | -53.93% |
| Dec 30, 2022 | 20.76B | -50.56% |
| Dec 31, 2021 | 41.98B | -36.86% |
| Jun 16, 2021 | 66.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.88B |
| Hansoh Pharmaceutical Group Company | 260.32B |
| JD Health International | 215.66B |
| WuXi Biologics | 164.43B |
| Innovent Biologics | 155.25B |
| Sino Biopharmaceutical | 124.24B |
| CSPC Pharmaceutical Group | 112.39B |
| Akeso | 111.46B |